×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EVH – evolent health, inc class a (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EVH
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/18
04:10 pm
evh
Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1
Medium
Report
Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1
12/3
08:29 am
evh
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at BTIG Research from $36.00 to $29.00. They now have a "buy" rating on the stock.
Medium
Report
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at BTIG Research from $36.00 to $29.00. They now have a "buy" rating on the stock.
11/22
10:40 am
evh
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at JPMorgan Chase & Co. from $45.00 to $15.00. They now have an "overweight" rating on the stock.
Low
Report
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at JPMorgan Chase & Co. from $45.00 to $15.00. They now have an "overweight" rating on the stock.
11/19
09:14 am
evh
Evolent Health, Inc. (EVH): This Small-Cap Stock Is Ready To Explode [Yahoo! Finance]
Low
Report
Evolent Health, Inc. (EVH): This Small-Cap Stock Is Ready To Explode [Yahoo! Finance]
11/18
09:27 am
evh
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $34.00 to $28.00. They now have an "outperform" rating on the stock.
Low
Report
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $34.00 to $28.00. They now have an "outperform" rating on the stock.
11/13
01:46 pm
evh
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Citigroup Inc. from $33.00 to $21.00. They now have a "buy" rating on the stock.
Low
Report
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Citigroup Inc. from $33.00 to $21.00. They now have a "buy" rating on the stock.
11/12
10:45 am
evh
Evolent Health, Inc. (NYSE: EVH) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $20.00 price target on the stock.
Low
Report
Evolent Health, Inc. (NYSE: EVH) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $20.00 price target on the stock.
11/11
09:25 am
evh
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Barclays PLC from $39.00 to $19.00. They now have an "overweight" rating on the stock.
Medium
Report
Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Barclays PLC from $39.00 to $19.00. They now have an "overweight" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
11/7/2024
04:10 pm
evh
evolent health, inc class a
MISS
Report
-45.6%
evolent health, inc class a
8/8/2024
04:10 pm
evh
evolent health, inc class a
BEAT
Report
26.5%
evolent health, inc class a
5/9/2024
04:10 pm
evh
evolent health, inc class a
BEAT
Report
-9.4%
evolent health, inc class a
2/22/2024
04:10 pm
evh
evolent health, inc class a
BEAT
Report
14.4%
evolent health, inc class a
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/11
04:57 pm
evh
Form 8-K Evolent Health, Inc. For: Dec 06
Medium
Report
Form 8-K Evolent Health, Inc. For: Dec 06
11/12
09:56 am
evh
Form SC 13G/A Evolent Health, Inc. Filed by: FMR LLC
Medium
Report
Form SC 13G/A Evolent Health, Inc. Filed by: FMR LLC
11/8
06:03 am
evh
Form 10-Q Evolent Health, Inc. For: Sep 30
High
Report
Form 10-Q Evolent Health, Inc. For: Sep 30
11/7
04:18 pm
evh
Form 8-K Evolent Health, Inc. For: Nov 07
High
Report
Form 8-K Evolent Health, Inc. For: Nov 07
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/26
Evolent Health Inc (NYSE: EVH) had its price target lowered by analysts at SunTrust Banks, Inc. from $16.00 to $12.00. They now have a "buy" rating on the stock.
31.4%
8/6 Evolent Health Announces Second Quarter 2019 Results 17.0%
11/27 Evolent Health Partner Passport Health Plan is Not Initially Selected for Kentucky Managed Medicaid Contract 15.8%
12/5 Form 4 Evolent Health, Inc. For: Dec 03 Filed by: WILLIAMS FRANK J 15.0%
11/5 Q3/2019 9/30/2019 EPS -0.090 ZacksConsensus -0.210 ActVsEst 0.120 - Beat 13.4%
4/29 Evolent Health to Participate in Upcoming Investor Conference 10.8%
1/15 Evolent Health Inc (NYSE: EVH) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 9.5%
5/29 Evolent Health Inc (NYSE: EVH) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 8.3%
8/12 IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolent Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm 7.0%
4/23 Evolent Health, Inc. to Release First Quarter 2020 Operating Results and Host Conference Call on Thursday, May 7, 2020 6.7%
8/6 Evolent Health Announces Second Quarter 2019 Results 17.0%
11/27 Evolent Health Partner Passport Health Plan is Not Initially Selected for Kentucky Managed Medicaid Contract 15.8%
12/5 Form 4 Evolent Health, Inc. For: Dec 03 Filed by: WILLIAMS FRANK J 15.0%
11/5 Q3/2019 9/30/2019 EPS -0.090 ZacksConsensus -0.210 ActVsEst 0.120 - Beat 13.4%
4/29 Evolent Health to Participate in Upcoming Investor Conference 10.8%
1/15 Evolent Health Inc (NYSE: EVH) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 9.5%
5/29 Evolent Health Inc (NYSE: EVH) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 8.3%
8/12 IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolent Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm 7.0%
4/23 Evolent Health, Inc. to Release First Quarter 2020 Operating Results and Host Conference Call on Thursday, May 7, 2020 6.7%
TOP News Decliners
5/29
Evolent Health Expands Partnership with Passport Health Plan to Support Medicaid Beneficiaries in the Commonwealth of Kentucky
-29.3%
3/4 Evolent Health Inc (NYSE: EVH) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -23.1%
9/11 Evolent Health Inc (NYSE: EVH) was given a new $10.00 price target on by analysts at Piper Jaffray Companies. They now have a "buy" rating on the stock. -14.5%
4/29 Form DEF 14A Evolent Health, Inc. For: Jun 09 -10.0%
12/2 Evolent Health Inc (NYSE: EVH) had its "overweight" rating re-affirmed by analysts at KeyCorp. They now have a $10.00 price target on the stock, down previously from $20.00. -8.3%
12/10 The Co-Founder of Evolent Health, Inc. (NYSE:EVH), Frank Williams, Just Bought 5.8% More Shares [Yahoo! Finance News] -7.4%
8/14 Glancy Prongay & Murray LLP Announces Investigation on Behalf of Evolent Health, Inc. Investors (EVH) -7.2%
3/12 Evolent Health Inc (NYSE: EVH) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -7.0%
8/13 EVOLENT HEALTH SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Evolent Health, Inc. - EVH -6.7%
11/27 Evolent Health Inc (NYSE: EVH) had its price target lowered by analysts at Piper Jaffray Companies to $10.15. They now have an "overweight" rating on the stock. -6.6%
3/4 Evolent Health Inc (NYSE: EVH) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -23.1%
9/11 Evolent Health Inc (NYSE: EVH) was given a new $10.00 price target on by analysts at Piper Jaffray Companies. They now have a "buy" rating on the stock. -14.5%
4/29 Form DEF 14A Evolent Health, Inc. For: Jun 09 -10.0%
12/2 Evolent Health Inc (NYSE: EVH) had its "overweight" rating re-affirmed by analysts at KeyCorp. They now have a $10.00 price target on the stock, down previously from $20.00. -8.3%
12/10 The Co-Founder of Evolent Health, Inc. (NYSE:EVH), Frank Williams, Just Bought 5.8% More Shares [Yahoo! Finance News] -7.4%
8/14 Glancy Prongay & Murray LLP Announces Investigation on Behalf of Evolent Health, Inc. Investors (EVH) -7.2%
3/12 Evolent Health Inc (NYSE: EVH) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -7.0%
8/13 EVOLENT HEALTH SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Evolent Health, Inc. - EVH -6.7%
11/27 Evolent Health Inc (NYSE: EVH) had its price target lowered by analysts at Piper Jaffray Companies to $10.15. They now have an "overweight" rating on the stock. -6.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: